RQM+, a medtech service provider with the world’s largest global team of regulatory and quality experts, has appointed Ronnie Mahofski as head of mergers and acquisitions (M&A).

With more than 20 years of experience in the medical technology industry, Mahofski has held various positions at RQM+, including overseeing M&A integration and business development. He previously served as VP of engineering for Circadiance and as a project manager for MEDRAD. In his new role at RQM+, Mahofski is responsible for identifying and pursuing acquisition opportunities that complement its core regulatory services and provide a range of fully integrated outsourced solutions to help get medtech products to market faster and ensure ongoing regulatory compliance. 

Mahofski said: “We’re rapidly becoming the organisation that will help medical device companies connect the dots from concept through market deployment and maintenance, expediting patient access to life-improving technologies. In the coming years, we will continue to expand our offerings to support medtech customers throughout the product lifecycle. They recognise the significant time and cost savings they can achieve by running many key processes in parallel through one trusted partner.”

Following RQM+’s recent acquisition of Jordi Labs, Mahofski is currently working with other potential acquisitions to help the company expand.